STAT3 and cancer: Nevertheless, as suggested by some experimental data this tolerance is not absolute and can be reversed either by removing the toxic blockade (11) or through modern technologies regulating antitumor T-cell activity by inhibiting the STAT3 pathway in tumor cells since STAT3 activity and increased levels are associated with poor cancer prognosis in patients (10, 15, 17).